SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Korea
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

DONGKOOK PHARMACEUTICAL CO.,LTD.

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
DONGKOOK PHARMACEUTICAL CO.,LTD.

Headquarters
7, Teheran-ro 108-gil Gangnam-gu Seoul; Seoul; Seoul; 135502
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Financial Auditors: E-CHON (2011)
Incorporation Date: October 15, 1968
Total Employees: 663

Tel: 02-2191-9800

Company Description

Sales increased over the year-earlier periods with rising price of main product Insadol and high awareness of oral cavity disease medicines.Stable profitability was maintained with steady sales cost ratio while most of material drugs are produced in its material synthesis plants.Pipeline is expanded into new business sectors including premature ejaculation medicine joint developed with CTC BIO. Growth trend will continue with rising demand for menopause medicine and skin ailment disease and launch
More

Key Executives

Lee,Yeong Uk President
Park,Jin Kyu Non-Executive Independent Director
Jeong,Gyu Jin Auditor
O,Heung Ju Vice President
Gwon,Gi Beom Vice Chairperson
More
SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
2013 H1
(non-cons)
2012 Y
(non-cons)
Audited Audited
Unit Thousands Thousands
Balance Sheet

Total Assets

XXX

XXX

Current Assets

XXX

XXX

Total Liabilities

XXX

XXX

Shareholders Equity

XXX

XXX

Current Liabilities

XXX

XXX

* All the accounts are in KRW.
Income Statement

Total Operating Revenue

XXX

XXX

Operational Profit (Loss)

XXX

XXX

Net Profit (Loss)

XXX

XXX

* All the accounts are in KRW.
Ratios
Profitability Ratios

Return on Assets (ROA)

XXX

XXX

Return on Equity (ROE)

XXX

XXX

Return on Sales (ROS)

XXX

XXX

Return on Capital

XXX

XXX

Gross Profit Margin

XXX

XXX

Efficiency Ratios

Current asset turnover

XXX

XXX

Asset Turnover

XXX

XXX

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XXX

XXX

EBITDA

XXX

XXX

Bookvalue (BV)

XXX

XXX

Net Cash

XXX

XXX

Liquidity Ratios

Current Ratio

XXX

XXX

Quick ratio

XXX

XXX

Doom's day ratio

XXX

XXX

Cash Flow to Debt

XXX

XXX

Leverage Ratios

Leverage ratio

XXX

XXX

Interest Coverage Ratio

XXX

XXX

Debt to equity

XXX

XXX

Debt to total assets

XXX

XXX

Long Term Debt to Capital

XXX

XXX

Market ratios

Price/Book Ratio

XXX

XXX

Market Cap / Net cash

XXX

XXX

Trend Ratios

Revenue Trend

XXX

XXX

Net Income Trend

XXX

XXX